NCT06591741View on ClinicalTrials.gov

PCA Administration in Prosthetic Joint Infection

NANot yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 31, 2026

Primary Completion Date

July 31, 2028

Study Completion Date

December 31, 2028

Conditions
Prosthetic Joint Infection
Interventions
DIETARY_SUPPLEMENT

Oral PCA

PCA 1,000 mg BID until surgery, held until anticoagulation, and resumed at 1,000 mg daily for 4 years

All Listed Sponsors
collaborator

Lanny Johnson, M.D.

UNKNOWN

collaborator

Leo Whiteside, M.D.

UNKNOWN

lead

Dr. Dean Reeves Clinic

OTHER

NCT06591741 - PCA Administration in Prosthetic Joint Infection | Biotech Hunter | Biotech Hunter